NL-OMON52737招募中不适用
Prediction of REsPonse to Antipsychotics using electRoEncephalography - PREPARE
niversitair Medisch Centrum Utrecht0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16 至 64（—）
入选标准
- •- Age between 16 and 55 years old
- •- Psychotic episode
- •- Patients who are going to start or recently have started antipsychotic
- •treatment (<2
- •weeks prior to baseline visit)
- •- The participant needs to understand the study and is able to provide written
- •informed consent.
排除标准
- •- Coercive measures. With exception of zorg machtiging if a patient wants to
- •start with antipsychotics voluntarily and the patient is competent of making
- •- A history of mental retardation
- •- Organic brain damage
- •- Organic psychosis
- •- Patients who are pregnant or patients who are breastfeeding.
研究者
相似试验
尚未招募
不适用
Prediction of REsPonse to Antipsychotics usingelectRoEncephalographyNL-OMON20422ZonMW100
已完成
不适用
Delayed Response to Antipsychotic Medication in PsychosisCTRI/2017/11/010391Goverment Medical College and Hospital60
进行中（未招募）
1 期
A Phase 3 Study to Determine the Antipsychotic Efficacy and Safety of ALKS 3831 in Adult Subjects with Acute Exacerbation of SchizophreniaSchizophreniaEUCTR2015-003373-15-HUAlkermes Inc401
进行中（未招募）
1 期
Study to evaluate the efficacy and safety of ALKS 3831 in adult patients who have an acute exacerbation of SchizophreniaMedDRA version: 19.1Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersSchizophreniaEUCTR2015-003373-15-BGAlkermes Inc390
进行中（未招募）
1 期
Study to evaluate the efficacy and safety of ALKS 3831 in adult patients who have an acute exacerbation of SchizophreniaMedDRA version: 18.1Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersSchizophreniaEUCTR2015-003373-15-SKAlkermes Inc390